...
首页> 外文期刊>Theoretical Biology and Medical Modelling >The homeostatic set point of the hypothalamus-pituitary-thyroid axis – maximum curvature theory for personalized euthyroid targets
【24h】

The homeostatic set point of the hypothalamus-pituitary-thyroid axis – maximum curvature theory for personalized euthyroid targets

机译:下丘脑-垂体-甲状腺轴的稳态设定点–最大曲率理论用于个性化的正常甲状腺目标

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Despite rendering serum free thyroxine (FT4) and thyrotropin (TSH) within the normal population ranges broadly defined as euthyroidism, many patients being treated for hyperthyroidism and hypothyroidism persistently experience subnormal well-being discordant from their pre-disease healthy euthyroid state. This suggests that intra-individual physiological optimal ranges are narrower than laboratory-quoted normal ranges and implies the existence of a homeostatic set point encoded in the hypothalamic-pituitary-thyroid (HPT) axis that is unique to every individual. Methods We have previously shown that the dose–response characteristic of the hypothalamic-pituitary (HP) unit to circulating thyroid hormone levels follows a negative exponential curve. This led to the discovery that the normal reference intervals of TSH and FT4 fall within the ‘knee’ region of this curve where the maximum curvature of the exponential HP characteristic occurs. Based on this observation, we develop the theoretical framework localizing the position of euthyroid homeostasis over the point of maximum curvature of the HP characteristic. Results The euthyroid set points of patients with primary hypothyroidism and hyperthyroidism can be readily derived from their calculated HP curve parameters using the parsimonious mathematical model above. It can be shown that every individual has a euthyroid set point that is unique and often different from other individuals. Conclusions In this treatise, we provide evidence supporting a set point-based approach in tailoring euthyroid targets. Rendering FT4 and TSH within the laboratory normal ranges can be clinically suboptimal if these hormone levels are distant from the individualized euthyroid homeostatic set point. This mathematical technique permits the euthyroid set point to be realistically computed using an algorithm readily implementable for computer-aided calculations to facilitate precise targeted dosing of patients in this modern era of personalized medicine.
机译:背景尽管尽管在正常人群中将血清游离甲状腺素(FT4)和促甲状腺激素(TSH)定义为甲状腺功能正常,但许多接受甲状腺功能亢进和甲状腺功能减退症治疗的患者始终处于亚正常状态,与疾病前的健康甲状腺功能正常状态不一致。这表明个体内的生理最佳范围比实验室引用的正常范围窄,并且暗示着存在于每个人唯一的下丘脑-垂体-甲状腺(HPT)轴中编码的稳态设定点。方法我们以前已经表明,下丘脑-垂体(HP)单位对循环甲状腺激素水平的剂量反应特征遵循负指数曲线。这导致发现,TSH和FT4的正常参考间隔落在该曲线的“膝盖”区域内,在该区域内,指数HP特性出现了最大曲率。基于此观察,我们开发了在HP特征的最大曲率点上定位正常甲状腺稳态的理论框架。结果原发性甲状腺功能减退症和甲状腺功能亢进症患者的甲状腺功能正常设定点可使用上述简约数学模型从其计算出的HP曲线参数中轻松得出。可以证明,每个人都有一个正常的甲状腺功能设定点,通常与其他人不同。结论在本论文中,我们提供证据支持以点为基础的方法来调整甲状腺功能靶点。如果这些激素水平与个体化的甲状腺功能正常设定点相距较远,则在实验室正常范围内呈现FT4和TSH可能在临床上不理想。该数学技术允许使用易于实现的算法来实际计算出甲状腺功能正常值,该算法可用于计算机辅助计算,以促进在当今个性化医学时代中患者的精确靶向给药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号